We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

This study has been withdrawn prior to enrollment.
(there was no participants who were enrolled in this study)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01663467
First Posted: August 13, 2012
Last Update Posted: October 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Soonchunhyang University Hospital
Information provided by (Responsible Party):
YOUNG HO KIM, Seoul National University Hospital
August 8, 2012
August 13, 2012
October 25, 2016
September 2014
September 2016   (Final data collection date for primary outcome measure)
Tinnitus Handicap Inventory (THI) [ Time Frame: 6 months ]
THI will be evaluated 6 months after TRT using smatrphone and web
Same as current
Complete list of historical versions of study NCT01663467 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
Efficacy of Internet and Smartphone Application-delivered TRT
The purpose of this study is to prove the efficacy of the internet and smartphone application-delivered tinnitus retraining therapy (TRT).
to investigate the effect of TRT with minimized counseling
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Tinnitus
  • Drug: Ginkgo biloba
    Ginexin-F 80mg tablet will be given twice a day for 6 months.
    Other Name: Ginexin-F
  • Behavioral: modified TRT

    modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.

    Ginexin-F 80mg tablet will be given twice a day for 6 months.

  • Active Comparator: Ginkgo biloba only
    control group Ginexin-F 80mg tablet will be given twice a day for 6 months.
    Intervention: Drug: Ginkgo biloba
  • Experimental: Ginkgo biloba + modified TRT

    experimental group modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.

    Ginexin-F 80mg tablet will be given twice a day for 6 months.

    Interventions:
    • Drug: Ginkgo biloba
    • Behavioral: modified TRT
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
September 2016
September 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • chronic subjective tinnitus

Exclusion Criteria:

  • THI < 18
Sexes Eligible for Study: All
20 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01663467
SNUH_YHK_TRT
No
Not Provided
Plan to Share IPD: No
YOUNG HO KIM, Seoul National University Hospital
Seoul National University Hospital
Soonchunhyang University Hospital
Study Chair: YOUNG HO KIM, MD., PhD Seoul National University Hospital
Seoul National University Hospital
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP